Hantavirus Infections in the United States: Diagnosis and Treatment

  • Gregory Mertz
  • Louisa Chapman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 394)

Abstract

In volume three of Antiviral Chemotherapy: New Directions for Clinical Application and Research, Dr. Karl Johnson described the spectrum and mechanism of action, pharmacokinetics, and toxicity of ribavirin.1 Clinical data supporting the use of intravenous ribavirin for several forms of viral hemorrhagic fever, including Lassa fever and hemorrhagic fever with renal syndrome (HFRS), are presented in detail elsewhere and will not be repeated in this chapter.1–3

Keywords

Hemorrhagic Fever With Renal Syndrome Deer Mouse Indian Health Service Pulmonary Wedge Pressure Lassa Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johnson KM. Ribavirin treatment of arenavirus, hantavirus, pneumo-virus and paramyxovirus disease: topical and systemic therapy. In: Mills J, Corey L (eds) Antiviral Chemotherapy: New Directions for Clinical Application and Research, Vol. 3. PTR Prentice Hall, Englewood Cliffs, New Jersey, p 229–249, 1993.Google Scholar
  2. 2.
    McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986; 314: 20–26.CrossRefPubMedGoogle Scholar
  3. 3.
    Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164: 1119–1127.CrossRefPubMedGoogle Scholar
  4. 4.
    Hjelle B, Jenison S, Mertz G, et al. Emergence of hantaviral disease in the southwestern United States. West J Med 1994; 161: 467–73.PubMedGoogle Scholar
  5. 5.
    Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330: 949–955.CrossRefPubMedGoogle Scholar
  6. 6.
    Outbreak of acute illness–southwestern United States, 1993. MMWR 1993; 42: 421–424.Google Scholar
  7. 7.
    Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262: 914–917.CrossRefPubMedGoogle Scholar
  8. 8.
    Spiropoulou CF, Morzunov S, Feldmann H, et al. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994; 200: 715–723.CrossRefPubMedGoogle Scholar
  9. 9.
    Hjelle B, Jenison S, Torrez-Martinez N, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses. J Virol 1994; 68: 592–596.PubMedGoogle Scholar
  10. 10.
    Nerurkar VR, Song K-J, Gajdusek DC, Yanagihara R. Genetically distinct hantavirus in deer mice. Lancet 1993; 342: 1058–1059.CrossRefPubMedGoogle Scholar
  11. 11.
    Nerurkar VR, Song K-J, Song JW, et al. Genetic evidence for a hantavirus enzootic in deer mice (Peromvscus maniculatus) a decade before the recognition of hantaviral pulmonary syndrome. Virology 1994; 204: 563–568.CrossRefPubMedGoogle Scholar
  12. 12.
    Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994; 51: 102–108.PubMedGoogle Scholar
  13. 13.
    Schmaljohn AL, Li D, Negley DL. Bressler DS,. Turell MJ, Korch GW, Ascher MS. Schmaljohn CS. Isolation and initial characterization of a newfound hantavirus from California. Virology 1995; 206: 96372.CrossRefGoogle Scholar
  14. 14.
    Childs JE, Ksiazek TG, Spiropoulou CF, et al. Serologic and genetic identification of Peromvscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994; 169: 1271–1280.CrossRefPubMedGoogle Scholar
  15. 15.
    Update: Hantavirus disease–United States, 1993. MMWR 1994; 42: 612–614.Google Scholar
  16. 16.
    Newly identified hantavirus - Florida, 1994. MMWR 1994; 43: 99, 105.Google Scholar
  17. 17.
    Hjelle B, Chavez-Giles F, Torrez-Martinez N, et al. Genetic identification of a novel hantavirus of the harvest mouse Reithrodontomys megalotis. J Virology 1994; 68: 6751–6754.PubMedGoogle Scholar
  18. 18.
    Wilson C, Hjelle B, Jenison S. Probable hantavirus pulmonary syndrome that occurred in New Mexico in 1975. Ann Intern Med 1994; 120: 813.Google Scholar
  19. 19.
    Goodman RA, Zaki S, Khan A, el al. Hantavirus pulmonary syndrome in 1978. Abstract H112a, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, Florida, 4–7 October 1994.Google Scholar
  20. 20.
    Zeitz PS, Butler JC, Cheek JE, Samuel MC, Childs JE, Shands LA, et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. Journal of Infectious Diseases 1995;171:864–70._Google Scholar
  21. 21.
    Hallin GW, Simpson SQ, Crowell RE. James DS. Koster FT, Mertz GJ, Levy H. Cardiopulmonary manifestations of the hantavinis pulmonary syndrome. Critical Care Medicine 1996;24: (In press).Google Scholar
  22. 22.
    Nolte KB, Feddersen RM. Foucar K, Zaki SR, Koster FT, Madar D, Merlin TL, McFeeley PJ, Umland ET, Zumwalt RE. Hantavirus pulmonary syndrome in the United States: a pathologic description of a disease caused by a new agent. Human Pathology, 1995; 26: 110–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Jenison S. Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virology 1994;68:30003006_Google Scholar
  24. 24.
    CDC. Progress in the development of hantavirus diagnostic assays–United States. MMWR 1993; 42: 770–1Google Scholar
  25. 25.
    Butler J, Peters CJ. Hantavimses and hantavirus pulmonary syndrome. Clin Infect Dis 1994;19:387–95 26.CrossRefPubMedGoogle Scholar
  26. 26.
    Hjelle B, Spiropoulou CF, Torrez-Martinez N, et al. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis 1994: 170: 1013–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Ketai LH, Williamson M.R. Telepak RJ, et al. Hantavirus pulmonary syndrome: Radiographic findings in 16 patients. Radiology 1994. 191: 665–668.PubMedGoogle Scholar
  28. 28.
    Chapman LE, Mertz G, Kahn AS, et al. Open label intravenous ribavirin for hantavirus pulmonary syndrome. Abstract Hill, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4–7 October, 1994.Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Gregory Mertz
  • Louisa Chapman

There are no affiliations available

Personalised recommendations